Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amos, E. H.
Right arrow Articles by Amos, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amos, E. H.
Right arrow Articles by Amos, W. R.

Annals of Surgical Oncology, Vol 3, Issue 5 431-436, Copyright © 1996 by Society of Surgical Oncology

ARTICLES

Postoperative radiotherapy for locally advanced colon cancer

E. H. Amos, W. M. Mendenhall, P. J. McCarty, J. O. Gage, J. L. Emlet, G. C. Lowrey, C. A. Peterson and W. R. Amos
Department of Radiation Oncology, West Florida Cancer Institute, Pensacola 32514-6050, USA.

BACKGROUND: The role of adjuvant postoperative radiotherapy for locally advanced colon cancer is not well documented. METHODS: Seventy-eight patients who underwent a complete resection of B2-C colon cancer received postoperative radiotherapy. Twenty-eight patients received < or = 45 Gy; 50 patients received 50-55 Gy. Twenty-seven patients received adjuvant fluorouracil-based chemotherapy. All patients were followed for a minimum of 3 years; no patients were lost to follow-up. RESULTS: The overall local control rate was 88%. The 5-year actuarial rate of local control was 96% after 50-55 Gy postoperative radiotherapy compared with 76% after < 50 Gy (p = 0.0095). Multivariate analysis of local control showed that only radiotherapy dose significantly influenced this end point. Cause-specific survival rates at 5 years were B2, 67%; B3, 90%; C1, 100%; C2, 61%; C3, 36%; and overall, 63%. Multivariate analysis of cause-specific survival showed that only stage significantly influenced this end point. Bowel obstruction caused by adhesions developed in three patients and required a laparotomy; radiation-induced sarcoma developed in one additional patient. CONCLUSIONS: Postoperative radiotherapy appears to reduce the risk of local recurrence in patients with locally advanced colon cancer. The optimal dose is probably 50-55 Gy at 1.8 Gy per fraction. Postoperative radiotherapy may improve cause-specific survival for patients with stages B3 and C2 cancers.


This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
A C Bateman, N J Carr, and B F Warren
The retroperitoneal surface in distal caecal and proximal ascending colon carcinoma: the Cinderella surgical margin?
J. Clin. Pathol., April 1, 2005; 58(4): 426 - 428.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Society of Surgical Oncology.